COPD guidelines updated to focus on triple therapy

6th August 2019

The National Institute for Health and Care Excellence (NICE) have amended the guidelines on Chronic Obstructive Pulmonary Disease (COPD) to further focus on triple therapy.

The development of the guidelines were supported through a consultation with stakeholders that took place earlier this year. Stakeholders involved in the consultation included numerous CCGs, Royal Colleges and pharmaceutical organisations, as well as NHS England and charities such as the British Thoracic Society and the Primary Care Respiratory Society.

COPD is a condition that makes breathing difficult, and according to the British Lung Foundation, there are 1.2million people in the UK with the condition and many more are still undiagnosed.

Education for Health’s Education Lead for COPD, Beverley Bostock, commented: “the latest addendum to the NICE COPD guidelines looks at the role for triple therapy in more detail than the original update. It is interesting to compare and contrast the recommendations made here with those made by GOLD in their 2019 update. The contrasts and similarities underline the fact that treatment decisions should be tailored to the individual needs of the patient.”

The additions to the guidelines supplement the existing recommendations, which centred on:

  • Managing exacerbations of COPD in primary care and in hospital
  • Diagnosing COPD using symptoms, spirometry and other tests
  • Multidisciplinary management of stable COPD, including physiotherapy, occupational therapy, nutrition and palliative care
  • Managing stable COPD using nebulisers, oral therapy and pulmonary rehabilitation

The full guidelines can be found on the NICE website.

Further Information:

  • Education for Health provides education and training for healthcare professionals delivering care for those with long term conditions. Our part-time accredited courses focus on COPD, Spirometry, Asthma, Diabetes, and CVD.
  • More information about our courses can be found on our website:
  • Alternatively, please contact our team on: or +44 (0)1926 836835.